Disseminated Endometrial Cancer Cells During Sonohysterography - Full Text View

Purpose

The purpose of study is to: 1) determine critical volume necessary to overcome tubal pressure and result in fluid dissemination and 2) evaluate functional viability of any disseminated tumor cells collected during SHG

Condition	Intervention
Endometrial Cancer	Procedure: Sonohysterography

MedlinePlus related topics:

Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Other, Open Label, Single Group Assignment

Official Title:	The Incidence of Disseminated Endometrial Cancer Cells During Sonohysterography and Their Functional Viability: a Prospective Study

Further study details as provided by University of Wisconsin, Madison:

Primary Outcome Measures:

determine the critical volume necessary to overcome tubal pressure and result in fluid dissemination during SHG [ Time Frame: during surgery ]

Secondary Outcome Measures:

evaluate the functional viability of any disseminated tumor cells collected during SHG [ Time Frame: during surgery ]

Enrollment:	25
Study Start Date:	January 2004
Study Completion Date:	August 2006
Primary Completion Date:	February 2006 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
A: Experimental	Procedure: Sonohysterography SHG during surgery for endometrial cancer.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Stage I endometrial Cancer Disease
State IIA endometrial Cancer Disease

Exclusion Criteria:

Prior tubal ligation
Prior bilateral salpingectomy

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00205023

Locations


United States, Wisconsin
	University of Wisconsin
	Madison, Wisconsin, United States, 53792

Sponsors and Collaborators

University of Wisconsin, Madison

Investigators


Principal Investigator:	David M Kushner, MD	University of Wisconsin, Madison

More Information

Study ID Numbers:	CO 03702
First Received:	September 13, 2005
Last Updated:	June 10, 2008
ClinicalTrials.gov Identifier:	NCT00205023
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Genital Diseases, Female

Endometrial Neoplasms

Genital Neoplasms, Female

Uterine Diseases

Uterine Neoplasms

Urogenital Neoplasms

Endometrial cancer

Additional relevant MeSH terms:

Neoplasms

Neoplasms by Site

ClinicalTrials.gov processed this record on October 16, 2008

Sponsored by:	University of Wisconsin, Madison
Information provided by:	University of Wisconsin, Madison
ClinicalTrials.gov Identifier:	NCT00205023